Endo International PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Endo International PLC with three other
companies in this sector in the United States:
Vertex Pharmaceuticals Inc
sales of $3.05 billion
of which 41%
Elanco Animal Health Inc
of which 38%
was Food Animal Ruminants Swine), and
H. Lundbeck A/S
of which 100%
During the year ended December of 2018, sales at
Endo International PLC were $2.95 billion.
decrease of 15.0%
versus 2017, when the company's sales were $3.47 billion.
Contributing to the drop in overall sales was the 55.6% decline
in Generics, from $2.28 billion to $1.01 billion.
There were also decreases in sales in
U.S. Branded - Specialty and Established P (down 9.9% to $862.83 million)
International Pharmaceuticals (down 38.1% to $142.47 million)